Medical Tests
Explore lab tests, blood work, and imaging exams with plain-language preparation and overview pages.
Browse Directory Sections
All medical tests (102,751)
Other
IRF-PAI - Physical therapy - week 1 [CMS Assessment]
Other
IRF-PAI - Physical therapy - week 2 [CMS Assessment]
Other
IRF-PAI - Quality indicators - admission during assessment period [CMS Assessment]
Other
IRF-PAI - Quality indicators - discharge during assessment period [CMS Assessment]
Other
IRF-PAI - Signature of persons completing the assessment during assessment period [CMS Assessment]
Other
IRF-PAI - Skin conditions - discharge during assessment period [CMS Assessment]
Other
IRF-PAI - Speech-language pathology services - week 1 [CMS Assessment]
Other
IRF-PAI - Speech-language pathology services - week 2 [CMS Assessment]
Other
IRF-PAI - Therapy information during assessment period [CMS Assessment]
Other
IRF-PAI - Therapy provided - week 1 [CMS Assessment]
Other
IRF-PAI - Therapy provided - week 2 [CMS Assessment]
Other
IRF-PAI v2.0 - Cognitive patterns - admission during assessment period [CMS Assessment]
Other
IRF-PAI v2.0 - Hearing, speech, and vision - admission during assessment period [CMS Assessment]
Other
IRF-PAI v2.0 - Medications - admission [CMS Assessment]
Other
IRF-PAI v2.0 - Quality indicators - admission during assessment period [CMS Assessment]
Other
IRF-PAI v2.0 - Quality indicators - discharge during assessment period [CMS Assessment]
Other
IRF-PAI v2.0 - Staff assessment for mental status [CMS Assessment]
Other
IRF-PAI v2.0 - Swallowing/nutritional status - admission [CMS Assessment]
Other
IRF-PAI v2.0, LCDS v4.00 - Special treatments, procedures, and programs - discharge during assessment period [CMS Assessment]
Other
IRF-PAI v3.0 - Cognitive patterns - admission during assessment period [CMS Assessment]
Other
IRF-PAI v3.0 - Hearing, speech, and vision - admission during assessment period [CMS Assessment]
Other
IRF-PAI v3.0 - Identification information during assessment period [CMS Assessment]
Other
IRF-PAI v3.0 - Medical Info during assessment period [CMS Assessment]
Other
IRF-PAI v3.0 - Quality indicators - admission during assessment period [CMS Assessment]
Other
IRF-PAI v3.0 - Quality indicators - discharge during assessment period [CMS Assessment]
Other
IRF-PAI v3.0 - Skin conditions - discharge during assessment period [CMS Assessment]
Other
IRF-PAI v3.0 - Special treatments, procedures, and programs - admission during assessment period [CMS Assessment]
Other
IRF-PAI v3.0 - Staff assessment for mental status during assessment period [CMS Assessment]
Other
IRF-PAI v3.0 - Swallowing/nutritional status - admission during assessment period [CMS Assessment]
Other
IRF-PAI v3.0, LCDS v3.00 - Program interruption dates during assessment period [CMS Assessment]
Other
IRF-PAI v3.0, LCDS v4.00 - Bladder and bowel - admission during assessment period [CMS Assessment]
Other
IRF-PAI v3.0, LCDS v4.00 - Current number of unhealed pressure injuries at each stage - admission during assessment period [CMS Assessment]
Other
IRF-PAI v3.0, LCDS v4.00 - Current number of unhealed pressure injuries at each stage - discharge during assessment period [CMS Assessment]
Other
IRF-PAI v3.0, LCDS v4.00 - Medications - admission during assessment period [CMS Assessment]
Other
IRF-PAI v3.0, LCDS v4.00 - Medications - discharge and expired during assessment period [CMS Assessment]
Other
IRF-PAI v3.0, LCDS v4.00 - Skin conditions - admission during assessment period [CMS Assessment]
Other
IRF-PAI v3.0, LCDS v4.00, OASIS E - Health conditions - discharge or expired or transfer during assessment period [CMS Assessment]
Other
IRF-PAI v3.0, MDS v1.17.1, 1.17.2 - Functional abilities and goals - admission [CMS Assessment]
Other
IRF-PAI v3.0, MDS v1.17.1, 1.17.2 - Functional abilities and goals - discharge [CMS Assessment]
Other
IRF-PAI v3.0, MDS v1.17.1, 1.17.2 - Mobility - admission performance during assessment period [CMS Assessment]
Other
IRF-PAI v3.0, MDS v1.17.1, 1.17.2 - Mobility - discharge performance during assessment period [CMS Assessment]
Other
IRF-PAI v3.0, MDS v1.17.1, 1.17.2 - Self-care - admission performance during assessment period [CMS Assessment]
Other
IRF-PAI v3.0, MDS v1.17.1, 1.17.2, OASIS E - Prior functioning: everyday activities during assessment period [CMS Assessment]
Other
IRF-PAI v3.0, MDS v1.17.1, 1.17.2, OASIS E - Self-care - discharge goal during assessment period [CMS Assessment]
Other
IRF-PAI v4.0 - Administrative information - discharge during assessment period [CMS Assessment]
Other
IRF-PAI v4.0 - Administrative information during assessment period [CMS Assessment]
Other
IRF-PAI v4.0 - Cognitive patterns - admission during assessment period [CMS Assessment]
Other
IRF-PAI v4.0 - Cognitive patterns - discharge during assessment period [CMS Assessment]
Other
IRF-PAI v4.0 - Health conditions - admission during assessment period [CMS Assessment]
Other
IRF-PAI v4.0 - Hearing, speech, and vision - admission during assessment period [CMS Assessment]
Other
IRF-PAI v4.0 - Identification information during assessment period [CMS Assessment]
Other
IRF-PAI v4.0 - Quality indicators - admission during assessment period [CMS Assessment]
Other
IRF-PAI v4.0 - Quality indicators - discharge during assessment period [CMS Assessment]
Other
IRF-PAI v4.0 - Special treatments, procedures, and programs - admission during assessment period [CMS Assessment]
Other
IRF-PAI v4.0 - Special treatments, procedures, and programs - discharge during assessment period [CMS Assessment]
Other
IRF-PAI v4.0 - Swallowing/nutritional status - admission during assessment period [CMS Assessment]
Other
IRF-PAI v4.0, LCDS v5.00 - Health conditions - discharge or expired during assessment period [CMS Assessment]
Other
IRF-PAI v4.0, LCDS v5.00 - Medications - admission during assessment period [CMS Assessment]
Other
IRF-PAI v4.0, LCDS v5.00 - Medications - discharge and expired during assessment period [CMS Assessment]
Other
IRF-PAI v4.0, LCDS v5.00 - Nutritional approaches - last 7D and discharge during assessment period [CMS Assessment]
Other
IRF-PAI v4.0, LCDS v5.00 - Swallowing/nutritional status - discharge during assessment period [CMS Assessment]
Other
IRF-PAI v4.0, LCDS v5.00, OASIS E - High risk drug classes - use and indication during assessment period [CMS Assessment]
Other
IRF-PAI v4.0, LCDS v5.00, OASIS E - Mood during assessment period [CMS Assessment]
Other
IRF-PAI v4.0, OASIS E - Hearing, speech, and vision - ROC, DC during assessment period [CMS Assessment]
Other
IRF-PAI v4.2, LCDS v5.1, MDS v1.19.1 - Functional abilities - admission during assessment period [CMS Assessment]
Other
IRF-PAI v4.2, LCDS v5.1, MDS v1.19.1 - Functional abilities - discharge during assessment period [CMS Assessment]
Other
IRF-PAIv3.0, MDS v1.17.1, 1.17.2 - Self-care - discharge performance during assessment period [CMS Assessment]
Blood test
IRF6 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Blood test
ISCN band level [#] Qualitative
Other
ISCN band level [#] in Amniotic fluid Qualitative by Molecular genetics method
Other
ISCN band level [#] in Chorionic villus sample Qualitative by Molecular genetics method
Blood test
ISOtretinoin [Mass/volume] in Serum or Plasma
Blood test
ISOtretinoin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Blood test
ISOtretinoin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Blood test
ITGA2B gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Blood test
ITGB3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Blood test
ITGB3 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
Blood test
ITPA gene g.9330C>A [Type] in Serum or Plasma by Molecular genetics method
Blood test
ITPA gene g.9381A>C [Type] in Serum or Plasma by Molecular genetics method
Other
IV contrast given [Identifier]
Other
IV contrast given [Volume]
Other
IV medication [Minimum Data Set]
Other
IV medications in last 14 days - while a resident [MDSv3]
Other
IV medications in last 14 days - while not a resident [MDSv3]
Other
IV number [Identifier]
Other
IV site NEMSIS
Blood test
IVD gene full mutation analysis in Blood or Tissue by Sequencing
Blood test
IVD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Blood test
Ibuprofen IgE Ab [Units/volume] in Serum
Blood test
Ibuprofen [Mass/volume] in Serum or Plasma
Blood test
Ibuprofen [Mass/volume] in Serum or Plasma --1 hour post dose
Blood test
Ibuprofen [Mass/volume] in Serum or Plasma --1.5 hours post dose
Blood test
Ibuprofen [Mass/volume] in Serum or Plasma --2 hours post dose
Blood test
Ibuprofen [Mass/volume] in Serum or Plasma --2.5 hours post dose
Blood test
Ibuprofen [Mass/volume] in Serum or Plasma --3 hours post dose
Blood test
Ibuprofen [Mass/volume] in Serum or Plasma --30 minutes post dose
Blood test
Ibuprofen [Mass/volume] in Serum or Plasma --pre dose
Blood test
Ibuprofen [Mass/volume] in Serum or Plasma by Screen method
Other
Ibuprofen [Mass/volume] in Urine
Other
Ibuprofen [Mass] of Dose